Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Standard Bupivacaine Interscalene Block Versus Single Injection Liposomal Bupivacaine Following Surgical Fixation of Proximal Humerus Fractures

NCT05084573 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05084573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05084573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Standard Bupivacaine Interscalene Block Versus Single Injection Liposomal Bupivacaine Following Surgical Fixation of Proximal Humerus Fractures
Lead sponsor
The University of Hong Kong
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2020
Completion date
March 31, 2023
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder fractures